The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD

被引:83
作者
Echevarria, C. [1 ,2 ]
Steer, J. [1 ]
Heslop-Marshall, K. [2 ,3 ]
Stenton, S. C. [3 ]
Hickey, P. M. [4 ]
Hughes, R. [4 ]
Wijesinghe, M. [5 ]
Harrison, R. N. [6 ]
Steen, N. [7 ]
Simpson, A. J. [2 ]
Gibson, G. J. [2 ]
Bourke, S. C. [1 ,2 ]
机构
[1] North Tyneside Gen Hosp, Rake Lane, Newcastle Upon Tyne NE29 8NH, Tyne & Wear, England
[2] Newcastle Univ, Inst Cellular Med, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[3] Royal Victoria Hosp, Newcastle Upon Tyne, Tyne & Wear, England
[4] Northern Gen Hosp, Sheffield, S Yorkshire, England
[5] Royal Cornwall Hosp, Truro, Cornwall, England
[6] Univ Hosp North Tees, Stockton On Tees, Cleveland, England
[7] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England
关键词
OBSTRUCTIVE PULMONARY-DISEASE; RISK-FACTORS; SAMPLE-SIZE; DECAF SCORE; BODE INDEX; MORTALITY; PROGNOSIS; INTERVENTION; VALIDATION; ADMISSION;
D O I
10.1136/thoraxjnl-2016-209298
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
100201 [内科学];
摘要
Background One in three patients hospitalised due to acute exacerbation of COPD (AECOPD) is readmitted within 90 days. No tool has been developed specifically in this population to predict readmission or death. Clinicians are unable to identify patients at particular risk, yet resources to prevent readmission are allocated based on clinical judgement. Methods In participating hospitals, consecutive admissions of patients with AECOPD were identified by screening wards and reviewing coding records. A tool to predict 90-day readmission or death without readmission was developed in two hospitals (the derivation cohort) and validated in: (a) the same hospitals at a later timeframe (internal validation cohort) and (b) four further UK hospitals (external validation cohort). Performance was compared with ADO, BODEX, CODEX, DOSE and LACE scores. Results Of 2417 patients, 936 were readmitted or died within 90 days of discharge. The five independent variables in the final model were: Previous admissions, eMRCD score, Age, Right-sided heart failure and Left-sided heart failure (PEARL). The PEARL score was consistently discriminative and accurate with a c-statistic of 0.73, 0.68 and 0.70 in the derivation, internal validation and external validation cohorts. Higher PEARL scores were associated with a shorter time to readmission. Conclusions The PEARL score is a simple tool that can effectively stratify patients' risk of 90-day readmission or death, which could help guide readmission avoidance strategies within the clinical and research setting. It is superior to other scores that have been used in this population.
引用
收藏
页码:686 / 693
页数:8
相关论文
共 49 条
[1]
Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort [J].
Agusti, Alvar ;
Edwards, Lisa D. ;
Celli, Bartolome ;
MacNee, William ;
Calverley, Peter M. A. ;
Muellerova, Hana ;
Lomas, David A. ;
Wouters, Emiel ;
Bakke, Per ;
Rennard, Steve ;
Crim, Courtney ;
Miller, Bruce E. ;
Coxson, Harvey O. ;
Yates, Julie C. ;
Tal-Singer, Ruth ;
Vestbo, Jorgen .
EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (03) :636-646
[2]
Inability of Providers to Predict Unplanned Readmissions [J].
Allaudeen, Nazima ;
Schnipper, Jeffrey L. ;
Orav, E. John ;
Wachter, Robert M. ;
Vidyarthi, Arpana R. .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 (07) :771-776
[3]
Short- and Medium-term Prognosis in Patients Hospitalized for COPD Exacerbation The CODEX Index [J].
Almagro, Pedro ;
Soriano, Joan B. ;
Cabrera, Francisco J. ;
Boixeda, Ramon ;
Alonso-Ortiz, M. Belen ;
Barreiro, Bienvenido ;
Diez-Manglano, Jesus ;
Murio, Cristina ;
Heredia, Josep L. .
CHEST, 2014, 145 (05) :972-980
[4]
[Anonymous], 2006, CLEAR AIR NAT STUD C
[5]
Impact on patients' health status following early identification of a COPD exacerbation [J].
Bourbeau, J. ;
Ford, G. ;
Zackon, H. ;
Pinsky, N. ;
Lee, J. ;
Ruberto, G. .
EUROPEAN RESPIRATORY JOURNAL, 2007, 30 (05) :907-913
[6]
Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation [J].
Brekke, P. H. ;
Omland, T. ;
Holmedal, S. H. ;
Smith, P. ;
Soyseth, V. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (03) :563-570
[7]
Glasgow supported self-management trial (GSuST) for patients with moderate to severe COPD: randomised controlled trial [J].
Bucknall, C. E. ;
Miller, G. ;
Lloyd, S. M. ;
Cleland, J. ;
McCluskey, S. ;
Cotton, M. ;
Stevenson, R. D. ;
Cotton, P. ;
McConnachie, A. .
BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
[8]
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease [J].
Calverley, Peter M. A. ;
Anderson, Julie A. ;
Celli, Bartolome ;
Ferguson, Gary T. ;
Jenkins, Christine ;
Jones, Paul W. ;
Yates, Julie C. ;
Vestbo, Jorgen ;
Calverley, P. M. A. ;
Anderson, J. A. ;
Celli, B. ;
Ferguson, G. T. ;
Jenkins, C. ;
Jones, P. W. ;
Knobil, K. ;
Yates, J. C. ;
Vestbo, J. ;
Cherniack, R. ;
Similowski, T. ;
Cleland, J. ;
Whitehead, A. ;
Wise, R. ;
McGarvey, L. ;
John, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) :775-789
[9]
Simple nomograms to calculate sample size in diagnostic studies [J].
Carley, S ;
Dosman, S ;
Jones, SR ;
Harrison, M .
EMERGENCY MEDICINE JOURNAL, 2005, 22 (03) :180-181
[10]
The care transitions intervention - Results of a randomized controlled trial [J].
Coleman, Eric A. ;
Parry, Carla ;
Chalmers, Sandra ;
Min, Sung-joon .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (17) :1822-1828